Clinical Outcomes of Treatment in Pediatric Medulloblastoma Based on Molecular Subgroup: A Single-center Experience.
Not Applicable
- Conditions
- MedulloblastomaMolecular Subgroupoverall survival
- Registration Number
- TCTR20200825004
- Lead Sponsor
- Ratchadapiseksompotch Fund,Faculty of Medicine, Chulalongkorn university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1.Patients diagnosed medulloblastoma with pathological confirmation.
2.Aged < 15 years old
3.Treated with surgery followed by craniospinal irradiation.
Exclusion Criteria
1.Incomplete medical records and radiotherapy treatment data.
2.Incomplete treatment
3.Other malignancy before diagnosis which can interfere the treatment outcome
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival 5 year Kaplan-Meier method, log rank test
- Secondary Outcome Measures
Name Time Method Event free survival 5 year Kaplan-Meier method, log rank test